Amagi Media Labs IPO lists near-flat at ₹360 on debut

Amagi Media Labs Limited listed its equity shares on the NSE and BSE on Wednesday, January 21, 2026, following a main-board IPO that ran from January 13 to January 16. Social media discussions through the week largely tracked the issue timeline, subscription figures, grey market premium (GMP) chatter, and the first traded price on listing day. The company had set a price band of ₹343 to ₹361 per share (face value ₹5), with bids starting at 41 shares and in multiples of 41 thereafter. The issue was priced at ₹361 per share, and the IPO size was reported as 4,95,46,221 equity shares aggregating up to about ₹1,788.62 crore. Allotment was finalised on January 19, with credit to demat scheduled for January 20 ahead of the listing. Market participants also circulated official links to the RHP and exchange pages as part of IPO tracking.

Key IPO dates that traders tracked

The IPO opened for public bidding on Tuesday, January 13, 2026, and closed on Friday, January 16, 2026. Anchor investor bidding was scheduled for Monday, January 12, 2026, one working day before the issue opened. The basis of allotment was finalised on Monday, January 19, 2026, as shared widely across investor forums. Initiation of refunds and credit of shares to demat were both indicated for Tuesday, January 20, 2026. The listing date was consistently communicated as Wednesday, January 21, 2026. Discussions also noted that the equity shares were proposed to be listed on both BSE and NSE. For many retail bidders, these milestones mattered more than broad commentary because they determined when money would be unblocked and when trading could begin. The dates below were the most repeated reference points in public posts.

Price band, issue price, and minimum application size

Amagi Media Labs fixed the price band at ₹343 to ₹361 per equity share. The face value of each equity share was ₹5, a detail that circulated in multiple IPO schedules. The issue price was reported at ₹361 per share. The minimum bid was 41 equity shares, and investors could bid in multiples of 41 thereafter. This lot size was frequently cited in retail-focused posts because it defined the minimum capital outlay. Some posts also highlighted that the issue was a main-board IPO, not an SME listing. The price band and lot size were among the most searched terms during the bidding window. Traders also watched how pricing and demand would translate into the first traded price on listing day. While opinions varied, the publicly shared numbers around band, lot size, and listing venue were consistent.

IPO size and how the offer was described

The IPO was described as comprising 4,95,46,221 equity shares of face value ₹5. It was also reported to aggregate up to about ₹1,788.62 crore (often rounded to ₹1,789 crore in posts). Social chatter repeatedly broke this into a fresh issue and an offer for sale (OFS) component. The fresh issue portion was cited at ₹816.00 crore, while the offer for sale was cited at ₹972.62 crore. These figures were typically shared in a single line summary alongside the band and the listing date. Investors used the issue size details mainly for context, rather than as a direct trading input for the listing session. The core takeaway across posts was the size and structure, not projections about post-listing financials. Since the company was preparing for a main-board debut, the volume of retail-facing explainers was higher than usual. The table below consolidates the key offer parameters as circulated.

Subscription chatter and what “30x+” meant in posts

Investor conversations repeatedly referenced the IPO being subscribed more than 30 times. The “30x+” figure became a shorthand for strong demand during the three-day bidding period. Several posts stated that the allotment was scheduled for January 19 after achieving over 30 times oversubscription. The subscription discussions were usually tied to practical questions, such as how to check allotment status and when shares would be credited. Some posts explicitly mentioned that investors could check allotment status on BSE and NSE websites, and also referenced the registrar MUFG Intime India. The tone of these discussions was largely process-driven rather than analytical. People compared their bid status, timeline expectations, and the typical steps between allotment and listing. The high subscription number was treated as a sentiment indicator, especially when combined with GMP updates. However, the same threads also reminded readers that oversubscription does not guarantee a particular listing outcome.

Grey market premium signals ahead of January 21

Ahead of the listing, posts cited a grey market premium of ₹19 per share. Based on that GMP, the “expected listing gain” was circulated at about 5.26%. These figures were presented as a market indicator rather than an official metric. The GMP references were typically paired with reminders of the listing date and the issue price. Many retail traders used this as a quick gauge of sentiment going into January 21. At the same time, GMP talk was mixed with updates on oversubscription and allotment finalisation. The common framing was that the shares were scheduled to commence trading on both NSE and BSE on January 21, providing the first opportunity to trade in the secondary market. In such posts, GMP was treated as directional and short-term. The key factual point was that ₹19 was the widely shared GMP ahead of listing.

Listing day: near-flat start captured in shared snapshots

On listing day, a widely shared snapshot showed the stock around ₹360 versus the issue price of ₹361. One circulating line item described this as “Listed Negative” and indicated a move of about -0.28% at the time of the snapshot. The same snapshot showed a ₹-1 change from ₹361 to ₹360, with a timestamp noted as 21-Jan-2026 8:29. Since the listing was on both NSE and BSE, posts generally referred to the debut as “on BSE and NSE” rather than one venue. The immediate takeaway in discussions was that the debut was close to the issue price, rather than a sharp premium. Some investors compared this with the earlier GMP of ₹19, focusing on the difference between informal expectations and actual opening indications. Others simply used it to decide whether to hold or exit quickly once trading opened. The most consistent factual claim was the near-flat ₹360 print versus ₹361.

Who managed the issue and where it was set to list

The equity shares were proposed to be listed on BSE Limited and the National Stock Exchange of India Limited. The book running lead managers (BRLMs) named in widely shared IPO notes were Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, Goldman Sachs (India) Securities Private Limited, IIFL Capital Services Limited, and Avendus Capital Private Limited. These names were commonly included in IPO schedule reposts and reminders. For investors, the BRLM list mattered mainly as a verification point that the information was tied to the formal offer documentation. Several posts also reiterated that the company had filed the red herring prospectus (RHP) with the RoC on January 7, 2026. The focus stayed on verifiable, process-oriented facts rather than opinions about valuation. On listing day, the exchange listing was the final milestone in a timeline that began with the anchor bidding date. The listing venues and lead managers were among the most repeated “static” facts across platforms.

Official documents, links, and how investors verified details

Posts repeatedly pointed readers to official sources for the RHP and offer information. The RHP was stated to be available on SEBI’s website, and on the websites of BSE and NSE. It was also referenced as available on the company’s website (amagi.com) and on the websites of the BRLMs. This link-sharing served a practical purpose, especially amid high engagement during the bidding window. Investors used the official pages to cross-check the price band, dates, and other IPO parameters. Separate discussions around allotment checks pointed to exchange websites and the registrar MUFG Intime India. The recurring advice was to rely on these official sources for confirmations on timelines like allotment and credit. The same posts also repeated the minimum bid quantity and the listing date. In short, the online conversation around Amagi’s IPO was heavily anchored to the published schedule and the first traded indications, rather than broader narrative claims.